TIDMMHC

RNS Number : 2894K

MyHealthChecked PLC

01 September 2021

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

MyHealthChecked plc

( " MyHealthChecked " or " the Company " )

Medical laboratory accreditation for COVID testing

ISO 15189:2012 accreditation confirms internationally recognised gold standard for MHC lab testing

MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, announces that it now has ISO 15189:2012 accreditation across the Company's COVID-19 testing service, a mark of confidence that the service meets internationally recognised gold standards for performance and competence.

The accreditation was granted following assessments by the United Kingdon Accreditation Service ("UKAS") , and ensures that the laboratories used as part of the MyHealthChecked(TM) COVID-19 testing service deliver a proficient and high-quality service, meeting the relevant legal requirements.

The MyHealthChecked(TM) COVID-19 at-home nasal swab kit and PCR laboratory testing service utilises the Company's own laboratory in Manchester, together with its partner laboratory provided by Yourgene Health plc, which also has received ISO 15189:2012 accreditation for testing and sequencing.

MyHealthChecked's services have been included as one of the suppliers on the Government list with "Fit to Fly", "Test to Release" and "Days 2 and 8" testing, and the Company has established a key commercial partnership with Boots UK Limited ("Boots") . The MyHealthChecked COVID-19 testing service is available via www.boots.com and across over 500 Boots stores in Great Britain.

Penny McCormick, Chief Executive Officer of MyHealthChecked Plc, said:

"We are delighted to now have in place accreditation across our COVID-19 testing service, which is a clear sign to our existing customers and potential new customers that our medical laboratories and operational systems are extremely rigorous and structured around best possible practice within the industry.

"I am incredibly proud of the MyHealthChecked team for maintaining these high standards, ensuring that we offer a reliable and efficient service to all of our partners."

The persons responsible for arranging the release of this Announcement on behalf of the Company are Penny McCormick, CEO, and Gareth Davies, Chief Financial and Operations Officer respectively.

For further information contact:

 
 MyHealthChecked plc                                                     www.myhealthchecked.com 
 P enny McCormick , Chief Executive                                              via Walbrook PR 
  Officer 
 Gareth Davies, Chief Financial and 
  Operations Officer 
 
 SPARK Advisory Partners Limited (NOMAD)                                Tel: +44 (0)20 3368 3550 
 Neil Baldwin 
 
 Oberon Capital Ltd (Broker)                                            Tel: +44 (0)203 179 5344 
 Mike Seabrook                                                mikeseabrook@oberoninvestments.com 
 
 Walbrook PR Ltd (Media &          Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com 
  IR) 
 Paul McManus / Alice Woodings                             Mob: +44(0)7980 541 893 / +44 (0)7407 
                                                                                         804 654

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online, and would be viable for over the counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

About UKAS - The United Kingdom Accreditation Service is the national accreditation body for the United Kingdom, appointed by government, to assess organisations that provide certification, testing, inspection and calibration services. UKAS has been working with the Department for Health and Social Care to develop a three stage UKAS accreditation process for private providers of COVID-19 testing. This scheme has been used for any providers of private COVID-19 testing requiring accreditation for their services.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEAKPFDDDFEFA

(END) Dow Jones Newswires

September 01, 2021 02:00 ET (06:00 GMT)

Concepta (LSE:CPT)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Concepta.
Concepta (LSE:CPT)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Concepta.